Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)
about
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)How I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Epigenetics of Peripheral B-Cell Differentiation and the Antibody ResponseTrials with 'epigenetic' drugs: an updateFOXP3: genetic and epigenetic implications for autoimmunityHistone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytesApplication of Mouse Models to Research in Hearing and BalanceUpdated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).New perspectives of valproic acid in clinical practice.A cross-species analysis method to analyze animal models' similarity to human's disease state.Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.Regulation of immune responses by histone deacetylase inhibitorsGenome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation.Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation ProgramsHIV-specific CD8⁺ T cells and HIV eradicationNovel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.Inflammation and tuberculosis: host-directed therapies.An Update on the Use of Immunomodulators in Primary Immunodeficiencies.Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
P2860
Q24623371-632B5146-ABFF-4C69-B4E2-1A9FB08E20F3Q24633207-EDE76105-50A0-416E-A8AE-7F9128A6324FQ24643047-08E4EF4F-B841-417F-B29F-CF5D4A2C3447Q26772330-1FCA5766-FC6B-486D-A43F-12240F88C678Q27000542-42610A68-7524-453A-9D6E-68B48723E69DQ27003398-CECD3B21-C75E-4161-B735-800A93ECC517Q27324527-D4BF64D9-D214-46D5-AF86-556F0E70F177Q28394265-042CD376-23A4-4205-9EA1-D1C8781B9076Q33420245-F33423A3-48FA-4873-8B5F-65E71DF25EBDQ34380256-4C82A035-E12A-4665-984D-4B06A7B202DFQ34530293-2F9692CF-B9E5-4CA6-BC47-9E6C36140F7DQ34647217-AF53CA59-8EAC-44C3-AE1F-A02C1CEC99A1Q35855571-CC8415FF-783A-42D9-9F37-31EC3FCDABFCQ36367583-9931766B-F3C6-4A1A-B780-0E58B4894439Q36509087-37BD032D-0DF3-4C46-BAD8-8BE53D55353CQ36515071-997EA7D0-4C73-4568-9A0C-76C0BCC4845BQ37248354-98951269-9D48-4E24-8EE8-0361D17A3D24Q38203352-6527DAEA-1855-4733-9050-874FEC3A740CQ39016299-E21407C5-B13E-4637-B794-243597EE4D45Q42700395-5849A06C-9336-4F10-8EB5-79D7EF279DF0Q51599902-052C2F97-8A61-422A-BDD4-DC6459E18CB8
P2860
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Valproic acid (VPA), a histone ...... oproliferative syndrome (ALPS)
@en
Valproic acid (VPA), a histone ...... proliferative syndrome (ALPS).
@nl
type
label
Valproic acid (VPA), a histone ...... oproliferative syndrome (ALPS)
@en
Valproic acid (VPA), a histone ...... proliferative syndrome (ALPS).
@nl
prefLabel
Valproic acid (VPA), a histone ...... oproliferative syndrome (ALPS)
@en
Valproic acid (VPA), a histone ...... proliferative syndrome (ALPS).
@nl
P2093
P2860
P1476
Valproic acid (VPA), a histone ...... oproliferative syndrome (ALPS)
@en
P2093
Alan T Remaley
Jeffrey I Cohen
Kenneth Steadman
Kennichi C Dowdell
Lesley Pesnicak
Stephen E Straus
V Koneti Rao
Victoria Hoffmann
P2860
P304
P356
10.1016/J.EXPHEM.2008.12.002
P577
2009-02-12T00:00:00Z